Gelteq Limited Ordinary Shares
Drug Manufacturers - Specialty & Generic
Healthcare
GELS
9.44 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.40
52 week high
4.79
high
1.43
52 week low
0.00
low
1.37
growth
-44.35 %
previous Close
1.37
P/E ratio
market cap
18.75 M
div yield
0
usd
Mar 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
-171.43 %
eps surprise
0.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
3.05 M
12.00 %
cost of revenue
0.00 %
top top